125742 45 S211 M5 c4591001 A 6mth 201114 hiv preferred terms

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 12 15 Documents

2

Document text

Level Term Code SOC
PT Acute HIV infection 10000807 INFECTIONS AND INFESTATION S
PT Asymptomatic HIV infection 10003581 INFECTIONS AND INFESTATION S
PT Blood HIV RNA 10049826 INVESTIGATIONS
PT Blood HIV RNA below assay limit 10049829 INVESTIGATIONS
PT Blood HIV RNA decreased 10049828 INVESTIGATIONS
PT Blood HIV RNA fluctuation 10076287 INVESTIGATIONS
PT Blood HIV RNA increased 10049827 INVESTIGATIONS
PT Congenital HIV infection 10010504 CONGENITAL, FAMILIAL AND GENETIC DISORDER S
PT CSF HIV escape syndrome 10081027 INFECTIONS AND INFESTATION S
PT CSF HIV virus identified 10081028 INVESTIGATIONS
PT HIV antibody 10058761 INVESTIGATIONS
PT HIV antibody positive 10058736 INVESTIGATIONS
PT HIV antigen 10058763 INVESTIGATIONS
PT HIV antigen positive 10058737 INVESTIGATIONS
PT HIV associated nephropathy 10070737 INFECTIONS AND INFESTATION S
PT HIV cardiomyopathy 10069658 INFECTIONS AND INFESTATION S
PT HIV carrier 10020159 INFECTIONS AND INFESTATION S
PT HIV enteropathy 10069691 INFECTIONS AND INFESTATION S
PT HIV infection 10020161 INFECTIONS AND INFESTATION S
PT HIV infection CDC category A 10075708 INFECTIONS AND INFESTATION S
PT HIV infection CDC category B 10075709 INFECTIONS AND INFESTATION S
PT HIV infection CDC category C 10075710 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group I 10020162 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group II 10020163 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group III 10020164 INFECTIONS AND INFESTATION S
PT HIV infection CDC group IV 10061519 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup A 10020166 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup B 10020167 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup C1 10020168 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup C2 10020169 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup D 10020170 INFECTIONS AND INFESTATION S
PT HIV infection CDC Group IV subgroup E 10020171 INFECTIONS AND INFESTATION S
PT HIV infection WHO clinical stage I 10064446 INFECTIONS AND INFESTATION S
PT HIV infection WHO clinical stage II 10064447 INFECTIONS AND INFESTATION S
PT HIV infection WHO clinical stage III 10064448 INFECTIONS AND INFESTATION S
PT HIV infection WHO clinical stage IV 10064456 INFECTIONS AND INFESTATION S
PT HIV lipodystrophy 10078720 INFECTIONS AND INFESTATION S
PT HIV meningoencephalitis 10083411 INFECTIONS AND INFESTATION S
PT HIV peripheral neuropathy 10065681 INFECTIONS AND INFESTATION S
PT HIV test positive 10020188 INVESTIGATIONS
PT HIV tropism identified 10080517 INVESTIGATIONS
PT HIV tropism test 10067158 INVESTIGATIONS
PT HIV viraemia 10077716 INFECTIONS AND INFESTATION S
PT HIV wasting syndrome 10050309 INFECTIONS AND INFESTATION S
PT HIV-2 infection 10020194 INFECTIONS AND INFESTATION S
PT HIV-associated neurocognitive disorder 10078164 INFECTIONS AND INFESTATION S
PT Papular pruritic eruption of HIV 10082425 INFECTIONS AND INFESTATION S
090177e198d550b7\Final\Final On: 10-Dec-2021 03:00 (GMT)
FDA-CBER-2022-5812-0219586
PT Perinatal HIV infection 10071049 INFECTIONS AND INFESTATION S
090177e198d550b7\Final\Final On: 10-Dec-2021 03:00 (GMT)
FDA-CBER-2022-5812-0219587